Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Hallowell

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Plos One|December 7, 2013
Motivations for undertaking DNA sequencing-based non-invasive prenatal testing for fetal aneuploidy: a qualitative study with early adopter patients in Hong KongHuso Yi, Nina Hallowell, Sian Griffiths, et al.
Journal of Medical Genetics|March 17, 2023
Providing recurrence risk counselling for parents after diagnosis of a serious genetic condition caused by an apparently de novo mutation in their child: a qualitative investigation of the PREGCARE strategy with UK clinical genetics practitionersAlison C Kay, Jonathan Wells, Nina Hallowell, et al.
Journal of Genetic Counseling|June 26, 2024
Professionals' views on providing personalized recurrence risks for de novo mutations: Implications for genetic counselingAlison C Kay, Jonathan Wells, Anne Goriely, et al.
BMC Medical Ethics|November 17, 2022
"I don't think people are ready to trust these algorithms at face value": trust and the use of machine learning algorithms in the diagnosis of rare diseaseNina Hallowell, Shirlene Badger, Aurelia Sauerbrei, et al.
Social Science & Medicine (1982)|April 7, 2009
Distinguishing research from clinical care in cancer genetics: theoretical justifications and practical strategiesNina Hallowell, Sarah Cooke, Gill Crawford, et al.
SSM. Qualitative Research in Health|July 10, 2023
Democratising or disrupting diagnosis? Ethical issues raised by the use of AI tools for rare disease diagnosisNina Hallowell, Shirlene Badger, Francis McKay, et al.
European Journal of Human Genetics : EJHG|May 23, 2025
Determining a role for Patient and Public Involvement and Engagement (PPIE) in genomic data governance for cancer careKatherine Sahan, Lesley Turner, Nina Hallowell, et al.
Genetic Testing|September 4, 2004
High-risk premenopausal women's experiences of undergoing prophylactic oophorectomy: a descriptive studyNina Hallowell, James Mackay, Martin Richards, et al.
BMJ (Clinical Research Ed.)|May 11, 2005
Perceptions and experiences of taking oral hypoglycaemic agents among people of Pakistani and Indian origin: qualitative studyJulia Lawton, Naureen Ahmad, Nina Hallowell, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 5, 2013
Genetic medicine and incidental findings: it is more complicated than deciding whether to disclose or notGillian Crawford, Nicola Foulds, Angela Fenwick, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Plos One|December 7, 2013
Motivations for undertaking DNA sequencing-based non-invasive prenatal testing for fetal aneuploidy: a qualitative study with early adopter patients in Hong KongHuso Yi, Nina Hallowell, Sian Griffiths, et al.
Journal of Medical Genetics|March 17, 2023
Providing recurrence risk counselling for parents after diagnosis of a serious genetic condition caused by an apparently de novo mutation in their child: a qualitative investigation of the PREGCARE strategy with UK clinical genetics practitionersAlison C Kay, Jonathan Wells, Nina Hallowell, et al.
Journal of Genetic Counseling|June 26, 2024
Professionals' views on providing personalized recurrence risks for de novo mutations: Implications for genetic counselingAlison C Kay, Jonathan Wells, Anne Goriely, et al.
BMC Medical Ethics|November 17, 2022
"I don't think people are ready to trust these algorithms at face value": trust and the use of machine learning algorithms in the diagnosis of rare diseaseNina Hallowell, Shirlene Badger, Aurelia Sauerbrei, et al.
Social Science & Medicine (1982)|April 7, 2009
Distinguishing research from clinical care in cancer genetics: theoretical justifications and practical strategiesNina Hallowell, Sarah Cooke, Gill Crawford, et al.
SSM. Qualitative Research in Health|July 10, 2023
Democratising or disrupting diagnosis? Ethical issues raised by the use of AI tools for rare disease diagnosisNina Hallowell, Shirlene Badger, Francis McKay, et al.
European Journal of Human Genetics : EJHG|May 23, 2025
Determining a role for Patient and Public Involvement and Engagement (PPIE) in genomic data governance for cancer careKatherine Sahan, Lesley Turner, Nina Hallowell, et al.
Genetic Testing|September 4, 2004
High-risk premenopausal women's experiences of undergoing prophylactic oophorectomy: a descriptive studyNina Hallowell, James Mackay, Martin Richards, et al.
BMJ (Clinical Research Ed.)|May 11, 2005
Perceptions and experiences of taking oral hypoglycaemic agents among people of Pakistani and Indian origin: qualitative studyJulia Lawton, Naureen Ahmad, Nina Hallowell, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 5, 2013
Genetic medicine and incidental findings: it is more complicated than deciding whether to disclose or notGillian Crawford, Nicola Foulds, Angela Fenwick, et al.
Pageof 8